Anticancer multimers (Advanced Proteome Therapeutics)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameAnticancer multimers (Advanced Proteome Therapeutics)
Drug Alias NameAnticancer protein-drug conjugates - Advanced Proteome TherapeuticsAPC-103APC-102APC-101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulatorsCell death stimulantsAngiogenesis inhibitors +[4] 
TargetsNot applicable
Therapy Area/IndicationsBreast NeoplasmsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Proteome Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Proteome Therapeutics
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsSarcoma

Other Information

ATC CodeN/A
Related LinksN/A